1.4. Analysis.
Comparison 1 COC: norgestimate (NGM) 180/215/250 µg + EE 25, Outcome 4 Breakthrough bleeding or spotting (cycle 13): weight (lb) > 155 versus ≤ 123.
Comparison 1 COC: norgestimate (NGM) 180/215/250 µg + EE 25, Outcome 4 Breakthrough bleeding or spotting (cycle 13): weight (lb) > 155 versus ≤ 123.